Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Leonardo Oliveira

Sports Medicine Weston, FL Medical Doctor

NPI 1871765958 CMS profile 986312

2950 Cleveland Clinic Blvd, Weston, FL 33331

Open in the dashboard

General payments

$63,673

82 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Leonardo Oliveira of Weston, FL is reported in the CMS Open Payments database as having received $63,673 across 82 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,112 11
2024 General $10,883 23
2023 General $37,484 28
2022 General $10,608 11
2021 General $2,399 6
2020 General $59 1
2019 General $127 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Leonardo Oliveira
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Leonardo Oliveira were reported at $2,112. Among 132 Sports Medicine profiles paid that year, the median was $99 and the middle half received between $33 and $256.

Show as a table
Year Leonardo Oliveira Sports Medicine median Middle half National median
2019 $127 $131 $46–$324 $163
2020 $59 $96 $34–$276 $114
2021 $2,399 $120 $33–$421 $132
2022 $10,608 $107 $31–$274 $149
2023 $37,484 $63 $25–$180 $160
2024 $10,883 $104 $28–$282 $164
2025 $2,112 $99 $33–$256 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Bioventus LLC $33,641 24 payments
  2. Trice Medical, Inc. $25,831 26 payments
  3. Tenex Health Inc. $2,505 8 payments
  4. Pacira Pharmaceuticals Incorporated $877 6 payments
  5. DePuy Synthes Sales Inc. $348 8 payments
  6. HydroCision, Inc. $168 1 payment
  7. Djo, LLC $156 4 payments
  8. Terumo BCT, Inc. $64 1 payment
  9. AbbVie, Inc. $34 2 payments
  10. Vertex Pharmaceuticals Incorporated $27 1 payment
  11. Other $21 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $22,066 15 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $19,119 9 payments
  3. Consulting Fee $18,448 14 payments
  4. Honoraria $2,000 3 payments
  5. Food and Beverage $1,886 39 payments
  6. Grant $80 1 payment
  7. Gift $74 1 payment
Products named General payments · program years 2019–2025
  1. L360 Thigh System $3,334 4 payments
  2. TENEX HEALTH TX $1,663 4 payments
  3. Iovera $877 6 payments
  4. MONOVISC $317 7 payments
  5. TENJET $168 1 payment
  6. ORTHOVISC $168 2 payments
  7. HARVEST SmartPrep $64 1 payment
  8. CMF $46 2 payments
  9. DALVANCE $34 2 payments
  10. PROCARE $30 1 payment
  11. Other $98 4 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 10 drugs

Part D claims

443

Median for Internal Medicine: 777

Drug cost

$8,375

Median for Internal Medicine: $73,373

Branded share of claims

2.7%

Median for Internal Medicine: 19.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diclofenac Sodium Generic 95 $4,427
Duloxetine Hcl Generic 61 $1,404
Gabapentin Generic 109 $1,079
Pregabalin Generic 18 $565
Celecoxib Generic 21 $236
Alendronate Sodium Generic 17 $204
Meloxicam Generic 75 $172
Methylprednisolone Generic 18 $142
Acetaminophen-Codeine Acetaminophen With Codeine Brand 12 $102
Tramadol Hcl Generic 17 $44

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 104,182 Part D prescribers listed as Internal Medicine; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 26 billing codes

Paid by Medicare

$76,473

Of which drugs: $14,463

Medicare patients

283

Average age 76

Services billed

2,761

178 women, 105 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 32%
Ischemic heart disease 30%
Chronic kidney disease 30%
Osteoporosis 29%
Depression 22%
Atrial fibrillation 18%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg J7318 Office 18 1,620 $8,123
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 66 406 $309

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

82 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record